New Key Statistics Module, Z-Score and F-Score
OTCPK:MDXXF Key Ratios
| Market Cap $ M | 5.72 |
| Enterprise Value $ M | 6.00 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 2.49 |
| Price/Sales | 4.10 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | -- |
| EPS (TTM) $ | -0.005 |
| Beneish M-Score | 3.53 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -29.99 |
| EV-to-EBITDA | -38.44 |
| PEG | -- |
| Shares Outstanding M | 95.94 |
| Net Margin (%) | -47.31 |
| Operating Margin % | -20.84 |
| Pre-tax Margin (%) | -47.31 |
| Quick Ratio | 0.59 |
| Current Ratio | 0.60 |
| ROA % (ttm) | -25.36 |
| ROE % (ttm) | -41.29 |
| ROIC % (ttm) | -13.47 |
| Dividend Yield % | -- |
| Altman Z-Score | 1.35 |
MDXXF Number of Guru Trades
MDXXF Volume of Guru Trades
Gurus Latest Trades with OTCPK:MDXXF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:MDXXF is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Pharmala Biotech Holdings Inc Insider Transactions
No Available Data
News about OTCPK:MDXXF
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers